For centuries, natural products (NPs) have served as powerful therapeutics against a variety
of human ailments. Nowadays, they still represent invaluable resources for the treatment of …

The development and spread of Mycobacterium tuberculosis multi-drug resistant strains still
represent a great global health threat, leading to an urgent need for novel anti-tuberculosis …

Tuberculosis (TB) is one of the primary causes of deaths due to infectious diseases. The
current TB regimen is long and complex, failing of which leads to relapse and/or the …

The evolution and spread of antimicrobial resistance (AMR) is recognized as a major threat
to global health and to healthcare systems, being the cause for almost 700,000 deaths …

Protein phosphorylation regulates a large variety of biological processes in all living cells. In
pathogenic bacteria, the study of serine, threonine, and tyrosine (Ser/Thr/Tyr) …

Tuberculosis (TB) causes millions of deaths every year, ranking as one of the most
dangerous infectious diseases worldwide. Because several pathogenic strains of …

Mycobacterium tuberculosis (Mtb) is an obligate human pathogen killing millions of people
annually. Treatment for tuberculosis is lengthy and complicated, involving multiple drugs …

Tuberculosis (TB) is still a worldwide public health burden, as more than 1.3 million deaths
are expected to be reported in 2021. Even though almost 20 million patients have completed …

Antibiotic resistance is a global and pressing concern. Our current therapeutic arsenal is
increasingly limited as bacteria are developing resistance at a rate that far outpaces our …

Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a growing public health
concern worldwide, especially with the emerging challenge of drug resistance to the current …